Filter
105
Featured
Recommendations
30
New Publications
6
Language
Document type
No document type
69
Training Material
14
Manuals
12
Guidelines
4
Fact sheets
3
Resource Platforms
2
Studies & Reports
1
Countries / Regions
Syria
3
Ukraine
3
Russia
3
Nepal
2
South Sudan
2
Western and Central Europe
2
Eastern Europe
2
Global
2
Kenya
1
Middle East and North Africa
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
9
Capacity Building
4
Countries
4
Key Resources
1
Session outline
•Introduction to psychoses.
•Assessment of psychoses.
•Management of psychoses.
•Follow-up.
•Review.
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm
...
Q5.SCOPING QUESTION: In individuals with psychotic disorders (including schizophrenia) who require long-term antipsychotic treatment, what is the safety and role of depot antipsychotic medication?
The new guide provides practical, first-line management recommendations for mental, neurological and substance use conditions. Contents include modules on assessing and managing conditions such as acute stress, grief, moderate-severe depressive disorder, post-traumatic stress disorder, epilepsy, and
...
В этом разделе «Руководства mhGAP по принятию мер в отношении психических и неврологических расстройств» приведены рекомендации по оценке и оказанию помощи при ост
...
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
It includes different activities for the different material provided in mhGAP
Session Outline
•General Principles
•Essentials of mental health care and clinical practice: Assessments
•Essentials of mental health care and clinical practice: Management
•Essentials of mental health care and clinical practice: Follow-up
•Reviews
DEP supporting material
• Person stories
• Role plays – role plays 3 and 4 are extra material for
supplementary activities
• Multiple choice questions
• Video links
This module aims to provide basic guidance on management of range of mental health complaints not coveredelsewhere in this guide. Some of these complaints may be similar to depression, but upon closer examamination are distinct from the conditions covered in this guide. Other mental health complaint
...
SUI supporting material
• Person stories
• Role plays
• Multiple choice questions
• Video link
Session outline
•Introduction to dementia
•Assessment of dementia
•Management of dementia
•Follow-up
•Review
SUI supporting material
• Person stories
• Role plays
• Multiple choice questions
• Video link
Activity 2: mhGAP SUI module – assessment and management
Q12. SCOPING QUESTION: In people with psychotic disorders, including schizophrenia and bipolar disorder, are recovery-oriented strategies enhancing vocational and economic inclusion (such as supported employment) feasible and effective?
“mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings” is a technical tool for implementation of the mhGAP Programme. The Intervention Guide has been developed through a systematic review of evidence, followed by an international consul
...
This module should always be used together with the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-specialized Health
Settings (WHO, 2010), which outlines relevant general
principles of care and management of a range of other
mental, neurological and substa
...
What can you expect?
As a future facilitator your role will be to learn about the structure of mhGAP-IG, how to teach the materials and utilize opportunities to prastice facilitation and supervision skills.
As a supervisor your role will be to serve as a point of reference for non-specialized heal
...
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
